Ute Friedrich

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Pratima Chowdary, Stefan Lethagen, Ute Friedrich et al. · Journal of Thrombosis and Haemostasis · 2015 · 220 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +13

Identification of Lck-binding Elements in Tip of Herpesvirus Saimiri

Jae U. Jung, Sabine M. Lang, Ute Friedrich et al. · Journal of Biological Chemistry · 1995 · 84 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Concizumab, an anti‐tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay

Emily K. Waters, J Sigh, Ute Friedrich et al. · Haemophilia · 2017 · 82 citations · Full text

Medicine, Hematology, Pharmacology +17

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

Hermann Eichler, Pantep Angchaisuksiri, Paul Knoebl et al. · Journal of Thrombosis and Haemostasis · 2018 · 78 citations · Full text

Medicine, Hematology, Pharmacology +15

Structural Investigation of the Binding of a Herpesviral Protein to the SH3 Domain of Tyrosine Kinase Lck^,

Kristian Schweimer, Silke Hoffmann, Finn Bauer et al. · Biochemistry · 2002 · 72 citations

Life Sciences, Biochemistry, Immunology +16